Keiji Hirata
- Molecular Biology top 10%
- Oncology top 2%
- Surgery top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cell Biology top 5%
- Co-authors
- Michael H. NathansonNorihiro SatoShiro KohiKazunori ShibaoAtsuhiro KogaYoshifumi NakayamaHideaki ItohXiaobo Cheng
- Topics
- Colorectal Cancer Treatments and Studies (35 papers)Genetic factors in colorectal cancer (23 papers)Gastric Cancer Management and Outcomes (21 papers)
- Cited by
- OncologyPhysiologyCell Biology
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- JapanUnited StatesTaiwan
In The Last Decade
Keiji Hirata
172 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.2k
- Oncology 1.1k
- Surgery 668
- Pulmonary and Respiratory Medicine 402
- Cell Biology 377
Countries citing papers authored by Keiji Hirata
This map shows the geographic impact of Keiji Hirata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiji Hirata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiji Hirata more than expected).
Fields of papers citing papers by Keiji Hirata
This network shows the impact of papers produced by Keiji Hirata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiji Hirata. The network helps show where Keiji Hirata may publish in the future.
Co-authorship network of co-authors of Keiji Hirata
This figure shows the co-authorship network connecting the top 25 collaborators of Keiji Hirata. A scholar is included among the top collaborators of Keiji Hirata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiji Hirata. Keiji Hirata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | KRAS野生型転移性結腸直腸癌(太平洋研究)患者におけるフルオロピリミジンの有無による第2線パニツムマブおよびイリノテカンの多施設オープンラベル無作為化第II相試験【JST・京大機械翻訳】 | 1 |
| 6 | The study on the safety and feasibility of gastroenterological surgery in patients undergoing antithrombotic therapy: Study protocol for a multicenter prospective cohort analysis (The GSATT Study) | 3 |
| 7 | [A Case of Small Cell Carcinoma of the Pancreas]. | 0 |
| 8 | 11 | |
| 9 | 7 | |
| 10 | Prospective phase II trial of second-line FOLFIRI in patients with advanced colorectal cancer including analysis of UGT1A1 polymorphisms: FLIGHT 2 study. | 9 |
| 11 | 0 | |
| 12 | Abdominal Wall Abscess and Sepsis induced by Stercoral Penetration of a Sigmoid Colostomy-Report of a Case- | 1 |
| 13 | Development of Assistant System for Ensemble in t-Room | 5 |
| 14 | 3 | |
| 15 | Significance of lymphangiogenesis as assessed by immunohistochemistry for podoplanin in patients with esophageal carcinoma. | 16 |
| 16 | 1 | |
| 17 | 5 | |
| 18 | Relationship between interleukin-12-expressing cells and antigen-presenting cells in patients with colorectal cancer. | 15 |
| 19 | Expression levels of thymidine phosphorylase (TP) and dihydropyrimidine dehydrogenase (DPD) in patients with gastrointestinal cancer. | 19 |
| 20 | [MASSIVE DOSES OF MITOMYCIN DURING SURGERY--THEORY AND RESULTS DURING PALLIATIVE EXCISION IN STOMACH CANCER]. | 1 |
About Keiji Hirata
Keiji Hirata is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 189 papers that have together received 2.8k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (35 papers), Genetic factors in colorectal cancer (23 papers) and Gastric Cancer Management and Outcomes (21 papers). The work is most often cited by research in Oncology (1.1k citations), Physiology (113 citations) and Cell Biology (377 citations). Keiji Hirata has collaborated with scholars based in Japan, United States and Taiwan. Frequent co-authors include Michael H. Nathanson, Norihiro Sato, Shiro Kohi, Kazunori Shibao, Atsuhiro Koga, Yoshifumi Nakayama, Hideaki Itoh, Xiaobo Cheng, Naoki Nagata and Noritaka Minagawa. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.